Browsing by Author Lucano-Landeros, S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
Adenoviral delivery of dominant-negative transforming growth factor ? type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.--
Adenoviral delivery of dominant-negative transforming growth factor β type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in ratsMarquez-Aguirre, A.; Sandoval-Rodriguez, A.; Gonzalez-Cuevas, J.; Bueno-Topete, M.; Navarro-Partida, J.; Arellano-Olivera, I.; Lucano-Landeros, S.; Armendariz-Borunda, J.--
Combinatorial gene therapy induces regression of hepatic encephalopathyGalvez-Gastelum, F.J.; Garcia-Bauelos, J.J.; Beas-Zárate, Carlos; Segura-Flores, A.; Gonzalez, H.; Chaparro-Huerta, V.; Salazar-Montes, A.; Sandoval-Rodriguez, A.S.; Bueno-Topete, M.; Lucano-Landeros, S.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Armendariz-Borunda, J.--
Combinatorial gene therapy induces regression of hepatic encephalopathyGalvez-Gastelum, F.J.; Garcia-Bauelos, J.J.; Beas-Zárate, Carlos; Segura-Flores, A.; Gonzalez, H.; Chaparro-Huerta, V.; Salazar-Montes, A.; Sandoval-Rodriguez, A.S.; Bueno-Topete, M.; Lucano-Landeros, S.; Medina-Preciado, D.; Gonzalez-Garcia, I.; Armendariz-Borunda, J.--
Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: Association of TGF-? polymorphismsVeras-Castillo, E.R.; Cardenas-Camarena, L.; Lyra-Gonzalez, I.; Munoz-Valle, J.F.; Lucano-Landeros, S.; Guerrerosantos, J.; Gonzalez-Ulloa, B.; Mercado-Barajas, J.L.; Sanchez-Parada, M.G.; Azabache-Wennceslao, R.; Armendariz-Borunda, J.--
Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: Association of TGF-β polymorphismsVeras-Castillo, E.R.; Cardenas-Camarena, L.; Lyra-Gonzalez, I.; Munoz-Valle, J.F.; Lucano-Landeros, S.; Guerrerosantos, J.; Gonzalez-Ulloa, B.; Mercado-Barajas, J.L.; Sanchez-Parada, M.G.; Azabache-Wennceslao, R.; Armendariz-Borunda, J.--
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.--
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CFlores-Contreras, L.; Sandoval-Rodriguez, A.S.; Mena-Enriquez, M.G.; Lucano-Landeros, S.; Arellano-Olivera, I.; Alvarez-Alvarez, A.; Sanchez-Parada, M.G.; Armendariz-Borunda, J.--